{"transactions":[{"id":940536,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69476,"kind":"person","name":"Hunter Robyn","position":1,"cik":"0001713932","reported_name":"Hunter Robyn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-14T00:53:08.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":13.3,"exercise_date":"2027-01-09","expiration_date":"2036-01-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001713932-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34956/000171393226000001/primary_doc.xml","form_type":"4"}},{"id":1093925,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69476,"kind":"person","name":"Hunter Robyn","position":1,"cik":"0001713932","reported_name":"Hunter Robyn","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-07-03T12:08:39.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":80000,"derivative":{"exercise_price":5.75,"exercise_date":"2026-07-01","expiration_date":"2035-07-01","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001654954-25-007734","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495425007734/section16.xml","form_type":"4"}},{"id":1334920,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69476,"kind":"person","name":"Hunter Robyn","position":1,"cik":"0001713932","reported_name":"Hunter Robyn","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-12-13T01:04:13.000Z","date":"2024-12-10","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":100000,"derivative":{"exercise_price":5.94,"exercise_date":"2025-12-10","expiration_date":"2034-12-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001654954-24-015475","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495424015475/section16.xml","form_type":"4"}},{"id":2237060,"issuer":{"id":979,"kind":"organization","name":"TENAX THERAPEUTICS, INC.","symbol":"TENX"},"owners":[{"id":69476,"kind":"person","name":"Hunter Robyn","position":1,"cik":"0001713932","reported_name":"Hunter Robyn","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-06-11T01:19:54.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6250,"derivative":{"exercise_price":0.62,"exercise_date":"2023-06-09","expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001654954-22-008237","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/34956/000165495422008237/section16.xml","form_type":"4"}},{"id":2287836,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":69476,"kind":"person","name":"Hunter Robyn","position":1,"cik":"0001713932","reported_name":"Hunter Robyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2022-04-29T20:25:46.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":28292,"price":3.13,"value":88553.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 62,500 shares on September 20, 2021, a total of 28,292 of such shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on September 21, 2021, was $3.11 to $3.14. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 163,877 shares, 34,208 shares are restricted stock units."}],"balance_after":163877,"source":{"system":"sec-edgar","filing":"0001104659-22-053623","document":"tm2213913-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465922053623/tm2213913-9_4seq1.xml","form_type":"4"}},{"id":3022368,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":69476,"kind":"person","name":"Hunter Robyn","position":1,"cik":"0001713932","reported_name":"Hunter Robyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2020-09-25T22:37:08.000Z","date":"2020-09-22","kind":"sale","acquired":false,"shares":28450,"price":4.38,"value":124611.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 62,500 shares on September 18, 2020, a total of 28,450 of such shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on September 22, 2020, was $4.36 to $4.41. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 192,169 shares, 62,500 shares are restricted stock units."}],"balance_after":192169,"source":{"system":"sec-edgar","filing":"0001104659-20-109014","document":"tm2031853-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465920109014/tm2031853-1_4.xml","form_type":"4"}},{"id":3328877,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":69476,"kind":"person","name":"Hunter Robyn","position":1,"cik":"0001713932","reported_name":"Hunter Robyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2019-12-31T21:02:25.000Z","date":"2019-06-03","kind":"purchase","acquired":true,"shares":2297,"price":1.1,"value":2526.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired as purchases made under the Company's Employee Stock Purchase Plan (\"ESPP\") during the ESPP offering period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include 21,437 shares automatically sold by the Company's plan administrator to cover taxes due upon vesting of certain shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 220,619 shares, 125,000 shares are restricted stock units."}],"balance_after":220619,"source":{"system":"sec-edgar","filing":"0001104659-19-077302","document":"tv530055_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465919077302/tv530055_form4.xml","form_type":"4"}},{"id":3747535,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":69476,"kind":"person","name":"Hunter Robyn","position":1,"cik":"0001713932","reported_name":"Hunter Robyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-30T22:26:24.000Z","date":"2018-11-23","kind":"sale","acquired":false,"shares":20370,"price":1.29,"value":26277.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 62,500 shares on November 20, 2018, a total of 20,370 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the sale transactions on November 23, 2018, was $1.28 to $1.34. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 239,759 shares, 187,500 shares are restricted stock units."}],"balance_after":239759,"source":{"system":"sec-edgar","filing":"0001144204-18-062675","document":"tv507899_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000114420418062675/tv507899_4.xml","form_type":"4"}}]}